Browse the latest stories and reports on MSF from various media outlets.

MSF's Judit Rius explains how a trade agreement could delay the development of generic medications, making lifesaving drugs unaffordable for many people.

More >

MSF's Rohit Malpani explains how trade agreements could prevent people in developing countries from having access to affordable, generic medications.

More >

The U.S. is pressuring countries in the Asia-Pacific region to accept regulations that will keep high prices on vital medicines that many people cannot afford.

More >

MSF is raising concerns about trade negotiations that could prevent India from manufacturing affordable, generic versions of newer AIDS medications.

More >

New WHO guidelines for HIV treatment are a major step forward, but they will be a challenge for countries such as South Africa to implement, according to MSF's Dr. Gilles van Cutsem. 

More >

A House subcommittee held a hearing on international trade disputes with India. Most of the event was devoted to U.S. drug company Pfizer's complaints about Indian policies that have fostered the country's billion-dollar generics industry.

More >

MSF's Judit Rius explains how the United States is standing in the way of an international treaty to fund research into neglected diseases.

More >

While drug companies celebrate price reductions that will allow girls in poor countries to be vaccinated against cervical cancer for $14 per patient, these prices are still out of reach for millions of people, MSF's Kate Elder explains.

More >

New vaccines, including for cervical cancer, are still priced too high to reach many girls in the world's poorest countries, according to MSF's Kate Elder.

More >

MSF's Kate Elder explains how the high price of vaccines prevents many children from being immunized.

More >

Pages